Björn Nodin
41 – 50 of 120
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Anti-CA15.3 and Anti-CA125 Antibodies and ovarian cancer risk : Results from the EPIC cohort
- Contribution to journal › Article
-
Mark
Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
- Contribution to journal › Article
-
Mark
Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases
- Contribution to journal › Article
-
Mark
Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment
- Contribution to journal › Article
-
Mark
Relationship between mismatch repair immunophenotype and long-term survival in patients with resected periampullary adenocarcinoma
- Contribution to journal › Article
-
Mark
Tumor-associated autoantibodies as early detection markers for ovarian cancer? A prospective evaluation
- Contribution to journal › Article
-
Mark
MMP7 modulation by short- and long-term radiotherapy in patients with rectal cancer
- Contribution to journal › Article
-
Mark
Ovarian cancer early detection by circulating CA125 in the context of anti-CA125 autoantibody levels : Results from the EPIC cohort
- Contribution to journal › Article
-
Mark
A novel monoclonal antibody targeting carboxymethyllysine, an advanced glycation end product in atherosclerosis and pancreatic cancer
- Contribution to journal › Article
-
Mark
Translational study reveals a two-faced role of RBM3 in pancreatic cancer and suggests its potential value as a biomarker for improved patient stratification
- Contribution to journal › Article
